Market for AI in Pharmaceutical Industry Globally to reach USD 3.88 Billion in 2025

reogma|Market for AI in Pharmaceutical Industry Globally to reach USD 3.88 Billion in 2025

The market for AI in the pharmaceutical industry is expected to increase from USD 303.50 million in 2019 to USD 3.88 billion in 2025, with a CAGR of 52.9%.

  • Definition / Scope
  • Market Overview
  • Market Trends
  • Industry Challenges
  • Technology Trends
  • Regulatory Trends
  • Market Size and Forecast
  • Market Outlook
  • Distribution Chain Analysis
  • Competitive Landscape
  • Key Market Players
  • Strategic Conclusion
  • References

Definition / Scope

AI is a broad area of computer science that makes machines replicate human intelligence with the system broadly called Machine Learning and Deep Learning. Other inter-related technologies include Supervised Learning, Unsupervised Learning, Natural Language Processing (NLP), Computer Vision, Speech and Robotics.

Machine Learning (ML) is an application of AI that provides systems with the ability to learn and improve from experiences and training, focusing on programs that can access data and use it to learn. Deep learning, a sub-set of ML, is a form of AI that mimics the neural networks of human body.

Machine is fed with terabytes of information then it studies them, learns from them, reiterates the process, and pivots its own moves. Supervised Learning uses labelled data to train a ML model while Unsupervised Learning is algorithm that take a set of data that contain only inputs and finds structure such as clustering.  AI is first coined in 1956 by Dartmouth professor named John McCarthy.

Pharmaceutical involves drug discovery as a major crucial stage in which the extraction of ingredients from natural products or chemical compound occurs followed by finding potential treatment of a disease. The goal of drug discovery is to identify small molecules that selectively modulate functions of target proteins.

Historically, guidance has been provided by naturally occurring compounds that have been used medicinally for hundreds or thousands of years. As such, the natural world has provided a large number of molecules from which many modern drugs have been developed. Modern pharmaceutical development employs strategies and methods of evaluating a very large number of molecules for specific desired targets.


This report is 12 mins read | Subscribe now to read further.

Access all reports on site for only US$9.99/mo


Leave a Reply

Next Post

Global Pharmaceutical industry to reach $1.5 Trillion by 2023

Tue Jun 9 , 2020
The market for AI in the pharmaceutical industry is expected to increase from USD 303.50 million in 2019 to USD 3.88 billion in 2025, with a CAGR of 52.9%. Definition / Scope Market Overview Market Trends Industry Challenges Technology Trends Regulatory Trends Market Size and Forecast Market Outlook Distribution Chain […]
reogma|Market for AI in Pharmaceutical Industry Globally to reach USD 3.88 Billion in 2025reogma|Market for AI in Pharmaceutical Industry Globally to reach USD 3.88 Billion in 2025

Tags

Tags

Newsletter Signup

Subscribe to our newsletter below and never miss the latest product or an exclusive offer.